This disconnect between lab findings and safe, regulated products is a major concern
New capillary networks formed through BPC-157-induced angiogenesis deliver oxygen-rich blood to hypoxic regions of the injured tendon, reversing the low-oxygen environment that otherwise delays cellular repair activity
This interaction increases cell surface ATP levels, which then activates P2X4 purinergic receptors
Property Detail Full Name Body Protection Compound 157 Amino Acids 15 (pentadecapeptide) Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular Weight ~1,419 g/mol Forms reviewed by FDA Free base and acetate salt FDA Status Not approved Active IND applications None (as of April 2026) Compounding status Under reclassification review (July 23-24, 2026) Is BPC-157 FDA Approved in 2026
Nevertheless, a pharmacy can not dispense, and a physician is not supposed to administer a medicine beyond its expiration date
IV therapy bypasses this limitation entirely, achieving blood concentrations 30-70 times higher than oral supplementation can provide
